PODXL and acute myeloid leukemia: In another report, the analysis of molecular and clinical data of 166 patients with acute myeloid leukemia from The Cancer Genome Atlas revealed a correlation between low expression of PODXL-targeting miR-199b and poor survival outcome [71].